Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania
Lambdin BH, Lorvick J, Mbwambo JK, Rwegasha J, Hassan S, Lum P, Kral AH. Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania. International Journal Of Drug Policy 2017, 45: 64-69. PMID: 28628854, PMCID: PMC6166640, DOI: 10.1016/j.drugpo.2017.05.043.Peer-Reviewed Original ResearchConceptsOpioid treatment programsHepatitis C virusOTP clinicHCV antibodiesAntibody serostatusHCV careDar es SalaamTreatment programHCV antibody prevalenceMultivariable Poisson regressionCross-sectional studyRoutine programmatic dataHIV-positiveMiddle-income countriesAdjusted analysisHIV servicesLast injectionMethadone patientsTreatment patientsC virusLeading causeAntibody prevalenceOverall seroprevalenceHigh burdenPWID